ACAndrew J. Cave

Andrew J. Cave

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Andrew J. Cave has a total of 101 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    A De Novo Pharmacist-Family Physician Collaboration Model in a Family Medicine Clinic in Alberta, Canada

    by Hoan Linh Banh, Andrew J. Cave

    Collaborative practice in health-care has proven to be an effective and efficient method for the management of chronic diseases. This study describes a de novo collaborative practice between a pharmacist and a family physician. The primary objective of the study is to describe the collaboration model between a pharmacist and family physician. The secondary objective is to describe the pharmacist workload. A list of patients who had at least one interaction with the pharmacist was generated and printed from the electronic medical record. There were 389 patients on the patient panel. The pharmacist had at least one encounter with 159 patients. There were 83 females. The most common medical condition seen by the pharmacist was hypertension. A total of 583 patient consultations were made by the pharmacist and 219 of those were independent visits. The pharmacist wrote 1361 prescriptions. The expanded scope of practice for pharmacists in Alberta includes additional prescribing authority. The pharmacists’ education and clinical experience gained trust from the family physician. These, coupled with the family physician’s previous positive experience working with pharmacists made the collaboration achievable.


  • Padiatric Asthma in Canada 2016: A cross-sectional study in primary care

    by Andrew Cave, Christina Gillies, Sylvia Aponte-Hao, Boglarka Soos, Tyler Williamson, Neil Drummond

    In Canada , 70% of paediatric asthma is managed in primary care. Different collection methods and venues produce a range of values for prevalence and patient demographics. We aimed to (1) describe both of these as seen in primary care in Canada using the national primary care database of the Canadian Primary Care Sentinel Surveillance Network which contains data from 1.8 million patients9 electronic medical records (2) the characteristics of children with asthma in Canada and (3) aspects of the management in primary care. We conducted a cross-sectional study of asthma in children between the ages of 1 and 17 in 2016 and the medications that they were prescribed. We used a validated search algorithm to extract data on children with asthma who had no gaps in the diagnosis greater than 3 years. The prevalence of asthma in this primary care cohort in 2016 was 18.07% (N=44,679). 52% males. Median age was 9 with a mean of 9.4. The median age of onset of the asthma was 7 years (mean 7.1). Prevalence reached a trough at age 12 and peaked at age 4 in both sexes and again in girls at age 17. Boys out numbered girls at all ages up to age 15. Twice as many girls had asthma onset at 16 or at 17 than did boys. Prevalence in the 1-3 year age group was 13%, before 6 was 17% and between 12 and 18 years was 20% Half the children had no recorded prescription for asthma in 2016. 13% had only ever had salbutamol as therapy. 66% had EVER had an ICS (7% in a combination inhaler) 1% had ever had prednisone . Though 26% had seen the physician in the last 12 months, only 4% had a recorded visit for asthma. Despite a high prevalence of childhood asthma , only 1% had severe asthma. Visits were irregular. More structure is needed.


  • Open Access

    Understanding Patient Perspectives on Medication Adherence in Asthma: A Targeted Review of Qualitative Studies

    by Suvina Amin, Mena Soliman, Andrew McIvor, Andrew Cave, Claudia Cabrera

    Adherence to asthma medications is generally poor and undermines clinical outcomes. Poor adherence is characterized by underuse of inhaled corticosteroids (ICS), often accompanied by over-reliance on short-acting β2-agonists for symptom relief. To identify drivers of poor medication adherence, a targeted literature search was performed in MEDLINE and EMBASE for articles presenting qualitative data evaluating medication adherence in asthma patients (≥ 12 years old), published from January 1, 2012 to February 26, 2018. A thematic analysis of 21 relevant articles revealed several key themes driving poor medication adherence, including asthma-specific drivers and more general drivers common to chronic diseases. Due to the episodic nature of asthma, many patients felt that their daily life was not substantially impacted; consequently, many harbored doubts about the accuracy of their diagnosis or were in denial about the impact of the disease and, in turn, the need for long-term treatment. This was further compounded by poor patient-physician communication, which contributed to suboptimal knowledge about asthma medications, including lack of understanding of the distinction between maintenance and reliever inhalers, suboptimal inhaler technique, and concerns about ICS side effects. Other drivers of poor medication adherence included the high cost of asthma medication, general forgetfulness, and embarrassment over inhaler use in public. Overall, patients’ perceived lack of need for asthma medications and medication concerns, in part due to suboptimal knowledge and poor patient-physician communication, emerged as key drivers of poor medication adherence. Optimal asthma care and management should therefore target these barriers through effective patient- and physician-centered strategies.


  • Open Access

    The Impact of a Training Program on Clinical Pharmacists on Pharmacy Clinical Services in a Tertiary Hospital in Hunan China

    by Ping Xu, Yi Yun Hu, Hai Yan Yuan, Da Xiong Xiang, Yan Gang Zhou, Andrew J Cave, Hoan Linh Banh

    Background: Prior to 2015, clinical consultation was the only clinical service provided by clinical pharmacists in Changsha Second Hospital. Between 2015 and 2017, a train-the-trainer program was implemented to train clinical pharmacists to provide pharmaceutical care and to conduct clinical research. The objective of the study is to examine the impact on the clinical services provided by pharmacists after the implementation of the train-the-trainer program. Patients and methods: Between 2004 and 2014, all completed clinical consultation activities were tallied and summarized. The results from the tallied consultation activities were used as a baseline for clinical activities provided by pharmacists prior to the training. A structured training program was implemented between 2015 and 2017 to train clinical pharmacists to provide pharmaceutical care. After the implementation of the training program was completed, all clinical activities provided by pharmacists between January 2017 and December 2017 were documented in the clinical workload form. The clinical activities completed by each pharmacist were tallied and summarized. Results: Between 2004 and 2014, a total of 6569 (average 657 per year) pharmacy consultations were requested and completed from a total of 44 departments. In 2017, a total of 15,078 hrs of clinical activities were logged. The pharmacists completed 3481 consultations in 2017 (an increase of 430%), averaging 316 consultations for each pharmacist and 271.8 hr per pharmacist. Over 2000 hrs (of the 15,078 hrs) were spent on direct patient care by the pharmacists. Conclusion: This study shows that there was a 430% increase in clinical pharmacy consultation services provided by the clinical pharmacists after the implementation of the training program. This is directly related to the number of well-trained pharmacists available. After the implementation of the train-the-trainer program, the range of services as well as the number of clinical services and clinical hours spent on providing pharmaceutical care have significantly increased.


  • Screening for AATD in a primary care COPD cohort in Canada

    by Andrew Cave, Natalia Stavila, Boglarka Soos, Stephanie Garies, Neil Drummond

    Alpha1-antitrypsin deficiency (AATD) is a manageable cause of COPD. Although prevalence rates vary with ethnicity, it is estimated to be 2% in COPD cohorts. In high-risk groups, however, prevalence rises to 5%. Testing for AATD in COPD patients is recommended by national guidelines, but in developed countries with low prevalence it is much more effective to test those who develop COPD before age 65, or who develop COPD despite never having smoked. In this study, we aimed to identify high-risk patients in a primary care electronic database in southern Alberta, Canada and to test if an electronic reminder would increase the number of tests performed in a group of primary care physicians (PCPs). We notified 224 PCPs of the eligible patients in their practice and reminded them to test patients with a simple 2-page leaflet of the national guidelines. We searched the database for tests performed up to January 2018 as well as tests performed after January 2018 when notification was sent by email. Prior to the intervention, 1879 tests had been performed by the PCPs, but only 300 of these patients had algorithm-defined COPD. The total number of tests had risen each year from 10 in 2005 to 248 in 2016. The top 5 testers among PCPs had together tested 29 patients under age 40, 143 patients between the ages of 31 and 60, and 7 patients over age 60. For each of these 5 testers, the numbers tested peaked in 2009 and 2014 (average 8.5 and 9.7, respectively) but dropped to <5 in 2017. We found that PCPs are testing patients other than COPD patients, which may be due to routine testing of infants. The high testing rates by a few PCPs and the spikes in testing in particular years merit further investigation.

  • Open Access

    Asthma and youth soccer: an investigation into the level of asthma awareness and training among youth soccer coaches

    by Chandu Sadasivan, Andrew Cave

    Purpose: Asthma is the most common chronic disease among children. Exercise-induced bronchoconstriction which is common in asthmatic patients also occurs in individuals with no prior asthma diagnosis. Despite this and the fact that soccer is a high ventilation sport, there are no validated asthma management protocols in place for soccer coaches. This study aims to address 1) soccer coaches’ current knowledge on asthma, 2) whether there is a need for asthma-related training, and 3) any barriers to administration of such training. Patients and methods: A total of 2,300 volunteer youth soccer coaches from the Edmonton Minor Soccer Association (EMSA) were invited to participate in completing a 22-question online survey. The survey was open for 1 month from June 8, 2018, to July 8, 2018. Results: There was a response rate of 22% (513 of 2,300). Respondents were on average, inexperienced coaches, coached younger age groups, and approximately one-third of respondents had personal experience with asthma (either themselves or their child had asthma). 93% of respondents had not received any asthma-related training at any coaching level, whether it be from EMSA or the Alberta Soccer Association. Coaches had strong knowledge on how to treat asthma attacks, but mixed levels of knowledge on asthma attack prevention. Experienced coaches were better at identifying the number of players with asthma on their team and the number of asthma-related incidents they had encountered as coaches. Coaches demonstrated a receptive attitude toward receiving asthma-related training, with 91% of respondents saying training would be beneficial and 69% of respondents saying training should be mandatory. Conclusion: The results of this study indicate that soccer coaches have limited knowledge regarding asthma management, acknowledge a need for asthma-related training, and are willing to participate in and could benefit from educational interventions as it pertains to their roles as coaches.


  • The 5As Team Program: Improving patient-centered obesity assessment and management in primary care

    by Denise L. Campbell-Scherer, Thea Luig, Jodie Asselin, Robin Anderson, Sheri Fielding, Melanie Heatherington, Michelle Borrowitz, Jacqueline Torti, Andrew Cave, Jeffrey A. Johnson, et al.

  • Open Access

    Every home should have one: the critical role of the research librarian

    by Andrew J Cave, Lana L Atkinson

    Today in Canada, most families own a car, a phone, a TV, and a computer. By many people’s standards, these are necessary devices with multiple purposes. They link our homes to a world that contains all manner of knowledge and information, and facilitate communication with those around us, as well as help us manage and organise our daily lives. Like these devices, research librarians are highly functional purveyors and communicators of a variety of important information. Not dissimilar to the software programs and applications that exist on our computers and tablets, research librarians are naturally inclined and trained to collect, funnel, and categorise knowledge and information. What’s more, research librarians do what others and their beloved devices cannot. They are avid investigators and organisers. If necessary, they use their experience and expertise to evaluate a plethora of information using …


  • Open Access

    ECG-Derived Spatial QRS-T Angle Is Associated with ICD Implantation, Mortality and Heart Failure Admissions in Patients with LV Systolic Dysfunction

    by P. Gladding, S. Gleeson, Y. Liao, C. Dugo, A. Cave, L. Zhou, J. Christiansen, T. Scott, L. Dawson, A. Gavin, et al.


  • Open Access

    Development of a validated algorithm for the diagnosis of paediatric asthma in electronic medical records

    by Andrew J Cave, Christina Davey, Elaheh Ahmadi, Neil Drummond, Sonia Fuentes, Seyyed Mohammad Reza Kazemi-Bajestani, Heather Sharpe, Matt Taylor

    An accurate estimation of the prevalence of paediatric asthma in Alberta and elsewhere is hampered by uncertainty regarding disease definition and diagnosis. Electronic medical records (EMRs) provide a rich source of clinical data from primary-care practices that can be used in better understanding the occurrence of the disease. The Canadian Primary Care Sentinel Surveillance Network (CPCSSN) database includes cleaned data extracted from the EMRs of primary-care practitioners. The purpose of the study was to develop and validate a case definition of asthma in children 1–17 who consult family physicians, in order to provide primary-care estimates of childhood asthma in Alberta as accurately as possible. The validation involved the comparison of the application of a theoretical algorithm (to identify patients with asthma) to a physician review of records included in the CPCSSN database (to confirm an accurate diagnosis). The comparison yielded 87.4% sensitivity, 98.6% specificity and a positive and negative predictive value of 91.2% and 97.9%, respectively, in the age group 1–17 years. The algorithm was also run for ages 3–17 and 6–17 years, and was found to have comparable statistical values. Overall, the case definition and algorithm yielded strong sensitivity and specificity metrics and was found valid for use in research in CPCSSN primary-care practices. The use of the validated asthma algorithm may improve insight into the prevalence, diagnosis, and management of paediatric asthma in Alberta and Canada.